New Clinical Data for Magtein® Presented at Vitafoods Europe

ThreoTech, a licensee of NuLiv Science, planned to showcase new clinical data on Magtein® (magnesium L-threonate) at Vitafoods Europe, a key industry event for ingredient suppliers and manufacturers. This highlights the increasing emphasis within the supplement industry on scientifically validated ingredients, particularly for categories such as cognitive health, sleep support, and stress management. Magtein® is a patented form of magnesium L-threonate. The research focuses on its reported potential to support cognitive function, improve sleep quality, and assist in stress reduction. These areas represent significant market opportunities for supplement brands seeking substantiated product offerings. ## Reinforcing Evidence-Based Formulations The planned presentation of new clinical findings at a prominent industry platform like Vitafoods Europe reflects a broader trend towards greater transparency and scientific rigour in the supplement sector. As demand for efficacy grows and regulatory scrutiny intensifies, ingredient suppliers are increasingly investing in and disseminating clinical research to validate their products. This approach supports formulators and brand owners in developing products with substantiated claims. Industry professionals attending Vitafoods Europe had the opportunity to learn more about the specifics of the data and its implications for product development. Such research is considered crucial for enabling manufacturers to differentiate their offerings by substantiating claims with scientific evidence. ## Addressing Key Consumer Demands The focus on cognitive function, sleep quality, and stress reduction with Magtein® directly addresses prominent health concerns among consumers globally. The cognitive health supplement segment is expanding, driven by an ageing population and increased awareness of brain performance. Similarly, sleep disturbances and chronic stress are widespread issues, contributing to demand for effective solutions. By providing clinical evidence, ThreoTech aims to support its partners in developing products that align with these consumer needs. The presentation at Vitafoods Europe served as a strategic platform for ThreoTech to engage with potential and existing partners, fostering collaboration and innovation in the cognitive and mental wellness categories.